Skip to main content
. 2022 Aug 20;12:14235. doi: 10.1038/s41598-022-18640-8

Table 1.

Clinical data of the patients according to the DeepECG-HFrEF algorithm.

DeepECG-HFrEF (+) (N = 600) DeepECG-HFrEF (−) (N = 691) Overall (N = 1291) p value
Clinical characteristics
Age, years 68.5 ± 13.5 67.2 ± 15.2 67.8 ± 14.4 0.102
Men 398 (66.3%) 325 (47.0%) 723 (56.0%)  < 0.001
BMI, kg/m2 23.4 ± 4.0 23.7 ± 3.9 23.6 ± 4.0 0.122
Current smoker 90 (15.0%) 88 (12.7%) 178 (13.8%) 0.257
Hypertension 379 (63.2%) 391 (56.6%) 770 (59.6%) 0.017
Diabetes mellitus 266 (44.3%) 237 (34.3%) 503 (39.0%)  < 0.001
Status of HF 0.027
De novo HF 163 (27.2%) 151 (21.9%) 314 (24.3%)
Acute decompensated HF 437 (72.8%) 437 (78.1%) 977 (75.7%)
HF class according to EF  < 0.001
HFpEF 90 (15.0%) 448 (64.8%) 538 (41.7%)
HFmrEF 86 (14.3%) 120 (17.4%) 206 (16.0%)
HFrEF 424 (70.7%) 123 (17.8%) 547 (42.4%)
Echocardiography
EF, % 33.5 ± 12.8 51.6 ± 12.9 43.2 ± 15.7  < 0.001
LVESV, mL 131.7 ± 72.2 76.7 ± 46.5 110.7 ± 69.0  < 0.001
LVEDV, mL 184.3 ± 81.9 131.3 ± 55.8 164.1 ± 77.4  < 0.001
E/A ratio 1.6 ± 1.2 1.3 ± 0.9 1.4 ± 1.0  < 0.001
Deceleration time, ms 159.6 ± 66.1 201.0 ± 92.3 182.9 ± 84.4  < 0.001
E/e' 21.9 ± 11.1 19.4 ± 13.0 20.5 ± 12.3 0.001
RVSP, mmHg 48.2 ± 14.7 44.6 ± 15.7 46.2 ± 15.3  < 0.001
Laboratory
eGFR, mL/min/1.73m2 57.6 ± 30.7 64.0 ± 32.7 60.9 ± 31.9 0.001
BNP, pg/mL 1745.4 ± 1547.4 1043.4 ± 1240.5 1444.5 ± 1464.5  < 0.001

BMI body mass index, BNP B-type natriuretic peptide, ECG electrocardiogram, EF ejection fraction, eGFR estimated glomerular filtration rate, HF heart failure, HFpEF heart failure with preserved ejection fraction, HFmrEF heart failure with mid-range ejection fraction, HFrEF heart failure with reduced ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end systolic volume, RVSP right ventricular systolic pressure.